There is now a wide consensus at recognizing social and economic circumstances as main determinants of an individual's health status. Nevertheless, characteristics relating to socioeconomic status (SES) are poorly described in research reports. The aim of the present review was to verify whether the SES of participants is adequately reported in interventional studies targeting Alzheimer's disease (AD), and to explore the impact of SES proxy measures on the efficacy of the considered medications.
Socioeconomic disparities in clinical trials on Alzheimer's disease. a systematic review / Canevelli, M; Bruno, G; Vico, C; Zaccaria, V; Lacorte, E; Iavicoli, I; Vanacore, N; Cesari, M. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - STAMPA. - 25:4(2018), pp. 626-643. [10.1111/ene.13587]
Socioeconomic disparities in clinical trials on Alzheimer's disease. a systematic review
Canevelli, M;Bruno, G;Zaccaria, V;
2018
Abstract
There is now a wide consensus at recognizing social and economic circumstances as main determinants of an individual's health status. Nevertheless, characteristics relating to socioeconomic status (SES) are poorly described in research reports. The aim of the present review was to verify whether the SES of participants is adequately reported in interventional studies targeting Alzheimer's disease (AD), and to explore the impact of SES proxy measures on the efficacy of the considered medications.| File | Dimensione | Formato | |
|---|---|---|---|
|
Canevelli_socioeconomic-disparities-in-clinical-trials-on-alzheimer’s-disease-a-systematic-review_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
264.44 kB
Formato
Adobe PDF
|
264.44 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
